Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study

The advent of direct-acting antivirals (DAAs) has transformed the landscape of hepatitis C virus (HCV) management. We aimed to prospectively (real-time) evaluate the feasibility of using a response-guided therapy approach, based on mathematical modeling of early viral kinetics, to reduce the duratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Etzion, Ohad, Dahari, Harel, Yardeni, David, Issachar, Assaf, Nevo-Shor, Anat, Cohen-Naftaly, Michal, Ashur, Yaffa, Uprichard, Susan L., Arbib, Orly Sneh, Munteanu, Daniela, Braun, Marius, Cotler, Scott J., Abufreha, Naim, Keren-Naus, Ayelet, Shemer-Avni, Yonat, Mor, Orna, Murad, Jayanah, Novack, Victor, Shlomai, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575564/
https://www.ncbi.nlm.nih.gov/pubmed/33082372
http://dx.doi.org/10.1038/s41598-020-74568-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575564/
https://www.ncbi.nlm.nih.gov/pubmed/33082372
http://dx.doi.org/10.1038/s41598-020-74568-x

Ejemplares similares